Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Nature Medicine2014Vol. 20(10), pp. 1126–1129
Citations Over TimeTop 1% of 2014 papers
Daphne A. Stanley, Anna N. Honko, Clement Asiedu, John C. Trefry, Annie W. Lau-Kilby, Joshua C. Johnson, Lisa E. Hensley, Virginia Ammendola, Adele Abbate, Fabiana Grazioli, Kathryn E. Foulds, Cheng Cheng, Lingshu Wang, Mitzi M. Donaldson, Stefano Colloca, Antonella Folgori, Mario Roederer, Gary J. Nabel, John R. Mascola, Alfredo Nicosia, Riccardo Cortese, Richard A. Koup, Nancy J. Sullivan
Related Papers
- → Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV(2019)122 cited
- → Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease(2021)97 cited
- → A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge(2018)48 cited
- → Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021(2022)18 cited
- → Recombinant vesicular stomatitis virus expressing Ebola virusglycoprotein (rVSV-EBOV), a new Ebola vaccine(2021)3 cited